Maria Pearse

1.7k total citations · 1 hit paper
25 papers, 614 citations indexed

About

Maria Pearse is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Maria Pearse has authored 25 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 8 papers in Radiation and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Maria Pearse's work include Prostate Cancer Diagnosis and Treatment (13 papers), Prostate Cancer Treatment and Research (10 papers) and Advanced Radiotherapy Techniques (8 papers). Maria Pearse is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (13 papers), Prostate Cancer Treatment and Research (10 papers) and Advanced Radiotherapy Techniques (8 papers). Maria Pearse collaborates with scholars based in New Zealand, Australia and Canada. Maria Pearse's co-authors include Andrew Kneebone, Ian Bissett, Carol Fraser‐Browne, Ryash Vather, Gerard Morton, Mahesh Parmar, Silvia Forcat, Pierre Richaud, Jayne F. Tierney and Meryem Brihoum and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Maria Pearse

25 papers receiving 606 citations

Hit Papers

Adjuvant or early salvage radiotherapy for the treatment ... 2020 2026 2022 2024 2020 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data
    2020 185 citations Claire L. Vale, David J. Fisher et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Pearse New Zealand 12 432 176 135 132 89 25 614
Samantha A. Seaward United States 12 696 1.6× 388 2.2× 109 0.8× 162 1.2× 117 1.3× 33 878
Julie Nossiter United Kingdom 14 320 0.7× 65 0.4× 95 0.7× 152 1.2× 83 0.9× 45 502
Luca Valle United States 12 371 0.9× 168 1.0× 61 0.5× 72 0.5× 138 1.6× 64 564
Jo-Åsmund Lund Norway 6 849 2.0× 280 1.6× 259 1.9× 210 1.6× 184 2.1× 7 1.0k
Wee Loon Ong Australia 13 317 0.7× 120 0.7× 146 1.1× 104 0.8× 109 1.2× 74 505
Perakaa Sethukavalan Canada 6 911 2.1× 89 0.5× 266 2.0× 193 1.5× 92 1.0× 12 987
Kiri A. Sandler United States 13 357 0.8× 89 0.5× 79 0.6× 90 0.7× 182 2.0× 26 516
Keen Hun Tai Australia 18 963 2.2× 609 3.5× 191 1.4× 129 1.0× 371 4.2× 30 1.3k
Emile N. van Lin Netherlands 10 360 0.8× 219 1.2× 71 0.5× 59 0.4× 173 1.9× 11 487
Mihai Ghilezan United States 11 564 1.3× 443 2.5× 151 1.1× 108 0.8× 125 1.4× 14 866

Countries citing papers authored by Maria Pearse

Since Specialization
Citations

This map shows the geographic impact of Maria Pearse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Pearse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Pearse more than expected).

Fields of papers citing papers by Maria Pearse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Pearse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Pearse. The network helps show where Maria Pearse may publish in the future.

Co-authorship network of co-authors of Maria Pearse

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Pearse. A scholar is included among the top collaborators of Maria Pearse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Pearse. Maria Pearse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kneebone, Andrew, Annette Haworth, Regina Bromley, et al.. (2022). Evaluating the utility of knowledge-based planning for clinical trials using the TROG 08.03 post prostatectomy radiation therapy planning data. Physics and Imaging in Radiation Oncology. 22. 91–97. 5 indexed citations
2.
Vale, Claire L., David J. Fisher, Andrew Kneebone, et al.. (2020). Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data. The Lancet. 396(10260). 1422–1431. 185 indexed citations breakdown →
3.
Jameson, Michael, Kirsty Wiltshire, Andrew Kneebone, et al.. (2019). Contour variation is a primary source of error when delivering post prostatectomy radiotherapy: Results of the Trans‐Tasman Radiation Oncology Group 08.03 Radiotherapy Adjuvant Versus Early Salvage (RAVES) benchmarking exercise. Journal of Medical Imaging and Radiation Oncology. 63(3). 390–398. 11 indexed citations
4.
5.
Sundaresan, Puma, Sandra Turner, Andrew Kneebone, et al.. (2017). A randomised controlled trial evaluating the utility of a patient Decision Aid to improve clinical trial (RAVES 08.03) related decision-making. Radiotherapy and Oncology. 125(1). 124–129. 15 indexed citations
6.
Tesson, Stephanie, Puma Sundaresan, Phyllis Butow, et al.. (2016). Knowledge, attitudes and decision-making preferences of men considering participation in the TROG RAVES Prostate Cancer Trial (TROG 08.03). Radiotherapy and Oncology. 119(1). 84–90. 3 indexed citations
7.
Kneebone, Andrew, Maria Pearse, Mark Sidhom, et al.. (2015). Optimizing Radiation Therapy Quality Assurance in Clinical Trials: A TROG 08.03 RAVES Substudy. International Journal of Radiation Oncology*Biology*Physics. 93(5). 1045–1051. 7 indexed citations
8.
Sundaresan, Puma, Sandra Turner, Andrew Kneebone, et al.. (2014). Do Screening Trial Recruitment Logs Accurately Reflect the Eligibility Criteria of a Given Clinical Trial? Early Lessons from the RAVES 0803 Trial. Clinical Oncology. 26(6). 348–352. 5 indexed citations
9.
Vather, Ryash, et al.. (2014). Clinical tumour size and nodal status predict pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer. International Journal of Colorectal Disease. 29(3). 301–307. 97 indexed citations
10.
Pearse, Maria, Carol Fraser‐Browne, Ian D. Davis, et al.. (2014). A P hase III trial to investigate the timing of radiotherapy for prostate cancer with high‐risk features: background and rationale of the Radiotherapy – Adjuvant Versus Early Salvage ( RAVES ) trial. British Journal of Urology. 113(S2). 7–12. 80 indexed citations
11.
Jackson, Christopher, Nieves Ehrenberg, Frank Frizelle, et al.. (2014). Rectal cancer: future directions and priorities for treatment, research and policy in New Zealand.. PubMed. 127(1395). 63–72. 2 indexed citations
12.
Sundaresan, Puma, Sandra Turner, Andrew Kneebone, Maria Pearse, & Phyllis Butow. (2011). Evaluating the utility of a patient decision aid for potential participants of a prostate cancer trial (RAVES-TROG 08.03). Radiotherapy and Oncology. 101(3). 521–524. 22 indexed citations
13.
Choo, Richard, Cyril Danjoux, Sandra Gardner, et al.. (2009). Prospective Study Evaluating Postoperative Radiotherapy Plus 2-Year Androgen Suppression for Post–Radical Prostatectomy Patients With Pathologic T3 Disease and/or Positive Surgical Margins. International Journal of Radiation Oncology*Biology*Physics. 75(2). 407–412. 16 indexed citations
14.
Choo, Richard, Cyril Danjoux, Sandra Gardner, et al.. (2009). Efficacy of Salvage Radiotherapy Plus 2-Year Androgen Suppression for Postradical Prostatectomy Patients With PSA Relapse. International Journal of Radiation Oncology*Biology*Physics. 75(4). 983–989. 28 indexed citations
15.
Pearse, Maria, Richard Choo, Cyril Danjoux, et al.. (2008). Prospective Assessment of Gastrointestinal and Genitourinary Toxicity of Salvage Radiotherapy for Patients With Prostate-Specific Antigen Relapse or Local Recurrence After Radical Prostatectomy. International Journal of Radiation Oncology*Biology*Physics. 72(3). 792–798. 28 indexed citations
16.
Choo, Richard, Maria Pearse, Cyril Danjoux, et al.. (2008). Analysis of Gastrointestinal and Genitourinary Morbidity of Postoperative Radiotherapy for Pathologic T3 Disease or Positive Surgical Margins After Radical Prostatectomy Using National Cancer Institute Expanded Common Toxicity Criteria. International Journal of Radiation Oncology*Biology*Physics. 72(4). 989–995. 16 indexed citations
17.
Pearse, Maria, Richard Choo, Cyril Danjoux, et al.. (2008). Prospective Evaluation of Gastrointestinal (GI) and Genitourinary (GU) Toxicity of Salvage Radiotherapy (RT) to the Prostate Bed for Patients with PSA Relapse after Radical Prostatectomy (RP). International Journal of Radiation Oncology*Biology*Physics. 72(1). S348–S348. 1 indexed citations
18.
North, J. B., et al.. (2007). Primary breast cancer of the vulva: Case report and literature review. Australian and New Zealand Journal of Obstetrics and Gynaecology. 47(1). 77–79. 18 indexed citations
19.
Tirona, R., Gerard Morton, Maria Pearse, Katharina E. Sixel, & P. C. OʼBrien. (2006). 166 Interfraction motion measured using 3D ultrasound and gold seed localization. Radiotherapy and Oncology. 80. S48–S48. 2 indexed citations
20.
Pearse, Maria, et al.. (1998). A model curriculum vitae: what are the trainers looking for?. PubMed. 59(4). 324–6. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samantha A. Seaward Breakdown of academic impact, for papers by Julie Nossiter Breakdown of academic impact, for papers by Luca Valle Breakdown of academic impact, for papers by Jo-Åsmund Lund Breakdown of academic impact, for papers by Wee Loon Ong Breakdown of academic impact, for papers by Perakaa Sethukavalan Breakdown of academic impact, for papers by Kiri A. Sandler Breakdown of academic impact, for papers by Keen Hun Tai Breakdown of academic impact, for papers by Emile N. van Lin Breakdown of academic impact, for papers by Mihai Ghilezan
Rankless by CCL
2026